Le Lézard
Classified in: Health, Business
Subject: CXP

b+b® Pain Relief Continues Explosive National Expansion


NASHVILLE, Tenn., June 21, 2018 /PRNewswire/ -- b+b®, the family owned health and wellness company founded on the principle of one-for-one giving, has added Publix Super Markets to its rapidly expanding list of retail locations. The "pain relief with heart" products, FDA/USP approved pain relievers including acetaminophen, ibuprofen and naproxen sodium, are now available in over 2600 retail locations nationwide. Priced the same or less than their branded competition, b+b® provides dye free options (an option not currently offered by any other national adult pain relief brand) and a unique flat bottle design that was created alongside the engineers behind the EOS lip balm for cool, innovative, on-the-go packaging.

The brand was founded by brothers Tony and Josh Breeden in January 2014 and launched in May 2017. For every b+b® pain relief product purchased, they donate one to their network of over 1000 free health clinics and rural health centers across the United States. To date, over 2.5 million doses have been donated.

The Breeden brothers share, "The very purpose of our company is to make helping others as easy as possible.  Partnering with supportive retailers like Publix helps us to achieve this goal on a large scale."

Publix is the largest employee-owned grocery chain in the United States with over 1200 stores in the southeastern United States and is one of the 10 largest-volume supermarket chains in the country employing over 190,000 people.

b+b® products are also available in Walmart stores nationwide, Woodman's stores throughout Wisconsin and Illinois, and online at amazon.com/betterbygiving. For more information please visit betterbygiving.com and follow us on social @BetterByGiving.

Media Contact:
Andrea McKinnon
[email protected] 
818-562-3136

SOURCE b+b


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: